<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Categories on emily.systems</title>
    <link>https://emily.systems/categories/</link>
    <description>Recent content in Categories on emily.systems</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    
	<atom:link href="https://emily.systems/categories/index.xml" rel="self" type="application/rss+xml" />
    
    
    
    <item>
      <title>Why Urbit?</title>
      <link>https://emily.systems/posts/why-urbit/</link>
      <pubDate>Sun, 25 Sep 2022 16:58:26 -0400</pubDate>
      
      <guid>https://emily.systems/posts/why-urbit/</guid>
      <description>&lt;p&gt;The internet could be about connecting with friends, but it&amp;rsquo;s not.&lt;/p&gt;
&lt;p&gt;It’s not easy for Alice to tell Bob and Charlie about her day, at least not directly. It’s much easier to ask a company to tell them for her (facebook, twitter, email, etc). Nobody wants to be have to ask companies to talk to their friends!&lt;/p&gt;
&lt;p&gt;&lt;a href=&#34;https://urbit.org/overview&#34;&gt;Urbit&lt;/a&gt; is a way to kick out the 3rd party.&lt;/p&gt;
&lt;h2 id=&#34;design-example&#34;&gt;Design example&lt;/h2&gt;
&lt;p&gt;Let&amp;rsquo;s build Snapchat – we want to send photos to friends. How would it typically be built, and how could we built it in Urbit?&lt;/p&gt;
&lt;h3 id=&#34;handling-users&#34;&gt;Handling users&lt;/h3&gt;
&lt;p&gt;The service needs authentication. This would require storing the usernames and passwords in a database. We&amp;rsquo;d also have to design some sort of password recovery system.&lt;/p&gt;
&lt;p&gt;With Urbit, the OS handles authentication. If you are logged in to the Urbit OS, you are already authenticated. It&amp;rsquo;s like SSO, except it&amp;rsquo;s your own.&lt;/p&gt;
&lt;h3 id=&#34;sending-data&#34;&gt;Sending data&lt;/h3&gt;
&lt;p&gt;Then, we have to handle the actual sending. Each time someone adds a friend, we&amp;rsquo;d have to store it to a database. Each time someone posts a photo, the photo gets uploaded to our storage and gets written to a database so each friend can view it.&lt;/p&gt;
&lt;p&gt;With Urbit, your own machine stores your friends list. Each time you post a photo, it reads your own friends list and sends it directly to them (Urbit handles the peer-to-peer network on the OS level: simply send it to the &lt;a href=&#34;https://urbit.org/overview/urbit-id&#34;&gt;Urbit ID&lt;/a&gt;). The photo only gets delivered to those you want it to.&lt;/p&gt;
&lt;h3 id=&#34;scaling&#34;&gt;Scaling&lt;/h3&gt;
&lt;p&gt;Let&amp;rsquo;s say your service becomes a lot more active than anticipated; we&amp;rsquo;d have to scale up the service. This could include increasing the amount of storage for photos, increasing the amount of uploads the server can handle at once, replication, sharding, and so on. This would increase complexity and the cost required to run the service. We would probably need to monetize our service. Maybe ads?&lt;/p&gt;
&lt;p&gt;With Urbit, there is no need to scale. Everything is peer to peer. Data isn&amp;rsquo;t being sent to a single centralized server but to your friends.&lt;/p&gt;
&lt;h3 id=&#34;shut-down&#34;&gt;Shut down&lt;/h3&gt;
&lt;p&gt;Let&amp;rsquo;s say you don&amp;rsquo;t want to run the service anymore: it&amp;rsquo;s been fun, but it&amp;rsquo;s too expensive. You shut it off, and all consumers are affected.&lt;/p&gt;
&lt;p&gt;With Urbit, there is nothing to &amp;lsquo;shut down&amp;rsquo;. It&amp;rsquo;ll exist as long as people use it.&lt;/p&gt;
</description>
    </item>
    
    
    
    <item>
      <title>Deleuzian Chemicals</title>
      <link>https://emily.systems/posts/deleuzian-chemicals/</link>
      <pubDate>Wed, 16 Jun 2021 19:28:03 -0500</pubDate>
      
      <guid>https://emily.systems/posts/deleuzian-chemicals/</guid>
      <description>&lt;h3 id=&#34;introduction&#34;&gt;Introduction&lt;/h3&gt;
&lt;p&gt;In 1972, Deleuze &amp;amp; Guattari published &lt;em&gt;Anti-Oedipus&lt;/em&gt; where they attempt to ground psychoanalysis in material conditions to show the historical contingency of the Freudian unconscious.&lt;/p&gt;
&lt;blockquote&gt;
&lt;p&gt;&amp;ldquo;&lt;em&gt;Our society produces schizos the same way it produces Prell shampoo or Ford cars&lt;/em&gt;&amp;rdquo; (245)&lt;/p&gt;
&lt;/blockquote&gt;
&lt;p&gt;In short, D&amp;amp;G&amp;rsquo;s schizoanalytic ontology is based on assemblages of &amp;ldquo;desiring-machines&amp;rdquo;. Machines create connections to produce flows of &lt;a href=&#34;https://en.wikipedia.org/wiki/Lack_(manque)&#34;&gt;non-lacking desire&lt;/a&gt;. The unconscious follows three syntheses:&lt;/p&gt;
&lt;h3 id=&#34;the-connective-synthesis-as-d1-receptorhttpsenwikipediaorgwikidopamine_receptor_d1&#34;&gt;The connective synthesis as &lt;a href=&#34;https://en.wikipedia.org/wiki/Dopamine_receptor_D1&#34;&gt;D1 receptor&lt;/a&gt;&lt;/h3&gt;
&lt;blockquote&gt;
&lt;p&gt;&amp;ldquo;&lt;em&gt;every machine is a machine connected to another machine.&lt;/em&gt;&amp;rdquo; (8)&lt;/p&gt;
&lt;/blockquote&gt;
&lt;p&gt;The connective synthesis of production is desiring-machines connecting with one another. D&amp;amp;G speak of it as a series of &amp;ldquo;&lt;em&gt;and&amp;hellip;and then&amp;hellip;and then&amp;hellip;&lt;/em&gt;&amp;rdquo; (5). This reminds me of dopamine acting as a reward system&lt;sup id=&#34;fnref:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt; to increase motivation for repetition. The connective synthesis risks falling into fixation, something that the addictive potential of dopamine&lt;sup id=&#34;fnref:2&#34;&gt;&lt;a href=&#34;#fn:2&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;2&lt;/a&gt;&lt;/sup&gt; does as well. For example, dopamine can invoke pathological behaviors involving repetition&lt;sup id=&#34;fnref:3&#34;&gt;&lt;a href=&#34;#fn:3&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;3&lt;/a&gt;&lt;/sup&gt; and compulsiveness&lt;sup id=&#34;fnref:4&#34;&gt;&lt;a href=&#34;#fn:4&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;4&lt;/a&gt;&lt;/sup&gt; which align with D&amp;amp;G&amp;rsquo;s connective synthesis.&lt;/p&gt;
&lt;p&gt;Eugene W. Holland writes:&lt;/p&gt;
&lt;blockquote&gt;
&lt;p&gt;&amp;ldquo;&lt;em&gt;At one extreme &amp;ndash; connection without disjunction &amp;ndash; you would have total fixation on an instinctually or habitually predetermined object [..] at the other &amp;ndash; disjunection without connection &amp;ndash; you would have total withdrawl from contact with reality&lt;/em&gt;&amp;rdquo; (The Cambridge Companion to Deleuze, 323)&lt;/p&gt;
&lt;/blockquote&gt;
&lt;h3 id=&#34;the-disjunctive-synthesis-as-d2-receptorhttpsenwikipediaorgwikidopamine_receptor_d2&#34;&gt;The disjunctive synthesis as &lt;a href=&#34;https://en.wikipedia.org/wiki/Dopamine_receptor_D2&#34;&gt;D2 receptor&lt;/a&gt;&lt;/h3&gt;
&lt;blockquote&gt;
&lt;p&gt;&amp;ldquo;&lt;em&gt;Freud stresses the importance of these disjunctive syntheses in Schreber&amp;rsquo;s
delirium in particular, but also in delirium as a general phenomenon.&lt;/em&gt;&amp;rdquo; (13)&lt;/p&gt;
&lt;/blockquote&gt;
&lt;p&gt;We can say the disjunective synthesis deals with the interruption of connections. The D2 receptor is very similar; it&amp;rsquo;s also associated with the novel&lt;sup id=&#34;fnref:5&#34;&gt;&lt;a href=&#34;#fn:5&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;5&lt;/a&gt;&lt;/sup&gt; rather than the continuation of the same. This is why D&amp;amp;G associate it with the series of &amp;ldquo;&lt;em&gt;&amp;hellip;either&amp;hellip;or&amp;hellip;or&amp;hellip;&lt;/em&gt;&amp;rdquo; (70). This reminds me of the symptoms of ADHD, such as the inability to focus at length&lt;sup id=&#34;fnref:6&#34;&gt;&lt;a href=&#34;#fn:6&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;6&lt;/a&gt;&lt;/sup&gt;. Within a Deleuzian lense, ADHD could be viewed as a subject being unable to hold onto connections, and one possible cause of ADHD is increased D2 activity&lt;sup id=&#34;fnref:7&#34;&gt;&lt;a href=&#34;#fn:7&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;7&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;
&lt;p&gt;In the same way the risk of the disjunctive synthesis is schizophrenia (according to D&amp;amp;G), the D2 receptor is one of the major hypotheses of schizophrenia&lt;sup id=&#34;fnref:8&#34;&gt;&lt;a href=&#34;#fn:8&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;8&lt;/a&gt;&lt;/sup&gt;. Many anti-psychotics act as antagonists for the D2 receptor&lt;sup id=&#34;fnref:9&#34;&gt;&lt;a href=&#34;#fn:9&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;9&lt;/a&gt;&lt;/sup&gt;, as well as many psychotomimetic drugs like Salvinorin and LSD act as partial agonists&lt;sup id=&#34;fnref:10&#34;&gt;&lt;a href=&#34;#fn:10&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;10&lt;/a&gt;&lt;/sup&gt;. The D2 receptor and the disjunctive synthesis are similar as they both break up repetitive behaviors and fixations, produce novel connections, and have the risk of breakdown.&lt;/p&gt;
&lt;h3 id=&#34;the-conjunctive-synthesis-as-nmdarhttpsenwikipediaorgwikinmda_receptor&#34;&gt;The conjunctive synthesis as &lt;a href=&#34;https://en.wikipedia.org/wiki/NMDA_receptor&#34;&gt;NMDAr&lt;/a&gt;&lt;/h3&gt;
&lt;p&gt;The conjunctive synthesis of consumption is what produces subjectivity. This subjectivity arises from the &amp;ldquo;consumption&amp;rdquo; of intensities caused from prior syntheses:&lt;/p&gt;
&lt;blockquote&gt;
&lt;p&gt;&amp;ldquo;&lt;em&gt;Where do these pure intensities come from? They come from the two preceding forces, repulsion and attraction&lt;/em&gt;&amp;rdquo; (19)&lt;/p&gt;
&lt;/blockquote&gt;
&lt;p&gt;He states that at zero-intensity is a catatonic body:&lt;/p&gt;
&lt;blockquote&gt;
&lt;p&gt;&amp;ldquo;&lt;em&gt;it is catatonic schizophrenia that gives its model to death. Zero intensity&lt;/em&gt;&amp;rdquo; (329)&lt;/p&gt;
&lt;/blockquote&gt;
&lt;p&gt;We can say that subjectivity is the opposite of catatonia. One way we can approach &amp;ldquo;zero intensity&amp;rdquo; is through &lt;a href=&#34;https://en.wikipedia.org/wiki/NMDA_receptor_antagonist&#34;&gt;NMDAr antagonists&lt;/a&gt; which can produce a loss of consciousness&lt;sup id=&#34;fnref:11&#34;&gt;&lt;a href=&#34;#fn:11&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;11&lt;/a&gt;&lt;/sup&gt;. Schizophrenia as a clinical entity (often catatonic, as D&amp;amp;G mention) is hypothesized as low NMDA activity&lt;sup id=&#34;fnref:12&#34;&gt;&lt;a href=&#34;#fn:12&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;12&lt;/a&gt;&lt;/sup&gt;. This means that the production of subjectivity could be associated with the activity of the NMDA receptor. A higher intensity or subjectivity could be associated with increasing NMDA activity, something psychedelics have the ability to do&lt;sup id=&#34;fnref:13&#34;&gt;&lt;a href=&#34;#fn:13&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;13&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;
&lt;p&gt;This image can show what intensive subjectivity may mean. Giving a normal brain (left) a 5-HT2a agonist causes glutamate to release&lt;sup id=&#34;fnref:14&#34;&gt;&lt;a href=&#34;#fn:14&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;14&lt;/a&gt;&lt;/sup&gt;, increasing NMDA receptor activity&lt;sup id=&#34;fnref:15&#34;&gt;&lt;a href=&#34;#fn:15&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;15&lt;/a&gt;&lt;/sup&gt; and thus increasing &amp;ldquo;subjectivity&amp;rdquo;. This gives us a picture of what increased subjectivity &lt;em&gt;may&lt;/em&gt; look like (right) according to Deleuze and Guattari.&lt;/p&gt;
&lt;p&gt;&lt;img src=&#34;http://u.cubeupload.com/n23/transparent.png&#34; alt=&#34;DMN psychedelic&#34;&gt;&lt;/p&gt;
&lt;section class=&#34;footnotes&#34; role=&#34;doc-endnotes&#34;&gt;
&lt;hr&gt;
&lt;ol&gt;
&lt;li id=&#34;fn:1&#34; role=&#34;doc-endnote&#34;&gt;
&lt;p&gt;&lt;a href=&#34;https://doi.org/10.1016/j.coph.2006.11.003&#34;&gt;https://doi.org/10.1016/j.coph.2006.11.003&lt;/a&gt; &lt;a href=&#34;#fnref:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:2&#34; role=&#34;doc-endnote&#34;&gt;
&lt;p&gt;&lt;a href=&#34;https://pubmed.ncbi.nlm.nih.gov/31905114/&#34;&gt;https://pubmed.ncbi.nlm.nih.gov/31905114/&lt;/a&gt; &lt;a href=&#34;#fnref:2&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:3&#34; role=&#34;doc-endnote&#34;&gt;
&lt;p&gt;&lt;a href=&#34;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858339/&#34;&gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858339/&lt;/a&gt; &lt;a href=&#34;#fnref:3&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:4&#34; role=&#34;doc-endnote&#34;&gt;
&lt;p&gt;&lt;a href=&#34;https://pubmed.ncbi.nlm.nih.gov/20136383/&#34;&gt;https://pubmed.ncbi.nlm.nih.gov/20136383/&lt;/a&gt; &lt;a href=&#34;#fnref:4&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:5&#34; role=&#34;doc-endnote&#34;&gt;
&lt;p&gt;&lt;a href=&#34;https://pubmed.ncbi.nlm.nih.gov/11304084/&#34;&gt;https://pubmed.ncbi.nlm.nih.gov/11304084/&lt;/a&gt; &lt;a href=&#34;#fnref:5&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:6&#34; role=&#34;doc-endnote&#34;&gt;
&lt;p&gt;One could easily make sense of more symptoms as &amp;lsquo;breaking connections&amp;rsquo;; more &lt;a href=&#34;https://www.cdc.gov/ncbddd/adhd/diagnosis.html&#34;&gt;here&lt;/a&gt; &lt;a href=&#34;#fnref:6&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:7&#34; role=&#34;doc-endnote&#34;&gt;
&lt;p&gt;&lt;a href=&#34;https://pubmed.ncbi.nlm.nih.gov/11730150/&#34;&gt;https://pubmed.ncbi.nlm.nih.gov/11730150/&lt;/a&gt; &lt;a href=&#34;#fnref:7&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:8&#34; role=&#34;doc-endnote&#34;&gt;
&lt;p&gt;&lt;a href=&#34;https://en.wikipedia.org/wiki/Dopamine_hypothesis_of_schizophrenia&#34;&gt;https://en.wikipedia.org/wiki/Dopamine_hypothesis_of_schizophrenia&lt;/a&gt; &lt;a href=&#34;#fnref:8&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:9&#34; role=&#34;doc-endnote&#34;&gt;
&lt;p&gt;&lt;a href=&#34;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112764/#__sec4title&#34;&gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112764/#__sec4title&lt;/a&gt; &lt;a href=&#34;#fnref:9&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:10&#34; role=&#34;doc-endnote&#34;&gt;
&lt;p&gt;&lt;a href=&#34;https://en.wikipedia.org/wiki/Dopamine_receptor_D2#Partial_agonists&#34;&gt;https://en.wikipedia.org/wiki/Dopamine_receptor_D2#Partial_agonists&lt;/a&gt; &lt;a href=&#34;#fnref:10&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:11&#34; role=&#34;doc-endnote&#34;&gt;
&lt;p&gt;&lt;a href=&#34;https://pubmed.ncbi.nlm.nih.gov/22291389/&#34;&gt;https://pubmed.ncbi.nlm.nih.gov/22291389/&lt;/a&gt; &lt;a href=&#34;#fnref:11&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:12&#34; role=&#34;doc-endnote&#34;&gt;
&lt;p&gt;&lt;a href=&#34;https://en.wikipedia.org/wiki/Glutamate_hypothesis_of_schizophrenia&#34;&gt;https://en.wikipedia.org/wiki/Glutamate_hypothesis_of_schizophrenia&lt;/a&gt; &lt;a href=&#34;#fnref:12&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:13&#34; role=&#34;doc-endnote&#34;&gt;
&lt;p&gt;&lt;a href=&#34;https://www.sciencedirect.com/science/article/abs/pii/S0006899304011813&#34;&gt;https://www.sciencedirect.com/science/article/abs/pii/S0006899304011813&lt;/a&gt; &lt;a href=&#34;#fnref:13&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:14&#34; role=&#34;doc-endnote&#34;&gt;
&lt;p&gt;&lt;a href=&#34;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743172/&#34;&gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743172/&lt;/a&gt; &lt;a href=&#34;#fnref:14&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:15&#34; role=&#34;doc-endnote&#34;&gt;
&lt;p&gt;&lt;a href=&#34;https://en.wikipedia.org/wiki/NMDA_receptor#Gating&#34;&gt;https://en.wikipedia.org/wiki/NMDA_receptor#Gating&lt;/a&gt; &lt;a href=&#34;#fnref:15&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;/ol&gt;
&lt;/section&gt;
</description>
    </item>
    
    
    
    
  </channel>
</rss>
